A carregar...

73 Changes in Palivizumab usage in Canada 2005–2017 (Data from CARESS registry)

BACKGROUND: Palivizumabis a monoclonal antibody for preventionof serious lower respiratory tract infection caused by respiratory syncytial virus (RSV) in high risk children. Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD), prematurity (≤ 35 weeks gestational age...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Paediatr Child Health
Main Authors: Mitchell, Ian, Saleem, Mahwesh, Li, Abby, Lanctot, Krista, Paes, Bosco
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543311/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!